4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-18-027941
President & CEO sold 130,000 shares at an average $84.05 ($10,926,066)
- President & CEO acquired 130,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
ROBIN HOWARD W · President & CEO
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-05-01 | Exercise or conversion : show line 1 in the form | +43,334 | $10.69 | $463,240 | 280,481 | D |
| 2018-05-01 | Sale : show line 2 in the form | −43,334 | $83.65 | $3,624,889 | 237,147 | D |
| 2018-05-02 | Exercise or conversion : show line 3 in the form | +43,333 | $10.69 | $463,230 | 280,480 | D |
| 2018-05-02 | Sale : show line 4 in the form | −43,333 | $85.63 | $3,710,605 | 237,147 | D |
| 2018-05-03 | Exercise or conversion : show line 5 in the form | +43,333 | $10.69 | $463,230 | 280,480 | D |
| 2018-05-03 | Sale : show line 6 in the form | −43,333 | $82.86 | $3,590,572 | 237,147 | D |
| Open-market sales · 130,000 sh · avg $84.05 · $10,926,066 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-05-01 | Exercise or conversion : show line 7 in the form Stock Option | −43,334 | 256,666 | D |
| 2018-05-02 | Exercise or conversion : show line 8 in the form Stock Option | −43,333 | 213,333 | D |
| 2018-05-03 | Exercise or conversion : show line 9 in the form Stock Option | −43,333 | 170,000 | D |
Loading xslF345X03/doc4.xml…